Clinical Trial Update: A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports on a pediatric Phase 1/2 study of Brentuximab Vedotin combined with doxorubicin, vinblastine, and dacarbazine in newly diagno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Adriamycin (doxorubicin)
• Brentuximab vedotin (Brentuximab vedotin)
• Dacarbazine (dacarbazine)
• Vinblastine (vinblastine)

Snippet

Sponsor: Takeda | Conditions: Hodgkin Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2021-06-01